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Comparison of Two Alternate Prostaglandin
Products in Yearling Beef Heifers

Alicia C. Lansford
T.L. Meyer
Rick N. Funston
Summary with Implications
Yearling heifers were administered 1 of 2
alternate prostaglandin products (Lutalyse
vs. Lutalyse HighCon), which differ in concentration of active ingredient and administration route. Timing of estrus, pregnancy
rate to AI, and final pregnancy rate did not
differ between treatments. Body weight and
ADG were also not affected by prostaglandin
treatment. These results indicate producers
can utilize Lutalyse HighCon, administered
subcutaneously (s.c.), to avoid injection
site blemishes and reduce carcass discounts
with no impact on estrus synchronization or
pregnancy rates.

Introduction
Estrus synchronization optimizes
labor and time, increases calf uniformity, decreases the length of the calving
season, and improves the ease of using AI.
Prostaglandin F2α (PG), a hormone used in
estrus synchronization, is typically injected
intramuscularly (i.m.) to regress the corpus
luteum, initiate estrus, and ultimately, cause
ovulation of the dominant follicle. The Beef
Quality Assurance program encourages animal pharmaceutical companies to develop
s.c. administration of injectable products,
decreasing the use of i.m. injections, which
can cause injection site lesions. Lutalyse
HighCon (12.5 mg/mL dinoprost tromethamine, Zoetis Animal Health, Parsippany,
NJ) has recently received labeling for either
s.c. or i.m. injection. It contains a higher
concentration of dinoprost tromethamine
than Lutalyse (5 mg/mL, Zoetis Animal
Health, Parsippany, NJ) and subsequent
dosage is decreased from 5 to 2 ml. The objective of the present study was to evaluate
© The Board Regents of the University of
Nebraska. All rights reserved.
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Figure 1. Melengestrol acetate–prostaglandin F2α (MGA-PG) protocol. Melengestrol acetate ( Zoetis
Animal Health, Parsippany, NJ) offered to each heifer for 14 d at a rate of 0.5 mg/d. On d 33, heifers were
administered either 5 ml i.m. Lutalyse (CONTROL, 5 mg/mL dinoprost tromethamine, Zoetis Animal
Health, n = 95) or 2 ml s.c. Lutalyse HighCon (HiCON, 12.5 mg/mL dinoprost tromethamine, Zoetis
Animal Health, n = 95).

the efficacy of 2 ml s.c. Lutalyse HighCon
compared with 5 ml i.m. Lutalyse in estrus
response and pregnancy rates in a melengestrol acetate (MGA)-PG protocol.

Procedure
Yearling, Angus-based heifers managed
at 2 locations were utilized to evaluate
the efficacy of 2 alternate PG (Lutalyse
vs. Lutalyse HighCon) products. Heifers
at location 1 (n = 100, 750 ± 7 lb, L1) were
maintained at West Central Research and
Extension Center (WCREC), North Platte,
NE. Heifers were offered a ration consisting of 13 lb/hd grass hay, 5 lb/hd wet corn
gluten feed, and 1 lb/hd of 1 of 2 mineral
supplements, on an DM basis.
Heifers were synchronized using a
MGA-PG protocol (Figure 1). Each heifer
was offered 0.5 mg/d of melengestrol
acetate (MGA, Zoetis Animal Health, Parsippany, NJ) pellets in their diet (d 1 to 14).
On d 33, heifers were blocked by previous
mineral treatment and assigned to receive 5
mL Lutalyse i.m. (CONTROL, n = 50) or 2
mL Lutalyse HighCon s.c. (HiCON, n =50).
A heat detection patch (Estrotect, Rockway
Inc., Spring Valley, WI) was applied at PG
injection. Heifers were managed together to
observe estrus continuously for 6 d.
Heifers were AI 12 h after estrus was
observed. Heifers were considered in estrus
when more than 50% of the rub-off coating
was removed on the Estrotect patch. Heifers
not detected in estrus (n = 16) were given
a s.c. injection of Lutalyse HighCon 6 d

after initial PG injection and placed with
2 bulls. Inseminated heifers were placed
in a separate pasture for 10 d before being
placed with bulls and heifers not detected
in estrus for a 60 d breeding season at a bull
to heifer ratio of 1:50. Pregnancy to AI was
diagnosed via transrectal ultrasonography
(Aloka, Hitachi Aloka Medical America
Inc., Wallingford, CT) 51 d after initial PG
injection and BW was recorded. Final pregnancy diagnosis occurred 78 d after initial
pregnancy diagnosis via transrectal ultrasonography to determine final pregnancy
rates and record BW.
A second group of yearling, Angus-
based crossbred heifers were managed at
the Kelly Ranch, Sutherland, NE (n = 90,
719 ± 9 lb; location 2, L2) and were offered a
ration containing 1 lb/d wet distillers grains,
5 lb/d grass hay, 7 lb/d corn silage, and 0.4
lb/d balancer pellet on a DM basis. Heifers
were synchronized with a similar MGA-PG
protocol as L1 and assigned randomly to
CONTROL (n = 45) or HiCON (n = 45)
treatment groups.
Heifers were AI 12 h after detection of
estrus. Heifers not expressing estrus by 96 h
were AI and given 2 ml Factrel i.m. (50 μg/
mL gonadorelin hydrochloride, Zoetis Animal Health, Parsippany, NJ). Ten d post AI,
2 bulls were placed with heifers for a 40 d
breeding season. Pregnancy to AI was diagnosed via transrectal ultrasonography 57 d
after PG injection and BW recorded. A final
pregnancy diagnosis and BW measurement
followed 50 d after initial pregnancy diagnosis on heifers not pregnant to AI.

Statistical Analysis
The PROC GLIMMIX procedure of SAS
(SAS Institute, Inc., Cary, N.C) was used for
statistical analyses with location and treatment in the class statement. Main effects
analyzed were estrus detection time points,
AI pregnancy rate, final pregnancy rate, BW
and ADG. Individual heifer was considered
the experimental unit. Means were declared
significant for both experiments at P ≤ 0.05
with 0.05 < P < 0.10 considered a tendency.

Results

Figure 2. Heifers were offered 0.5 mg/d melengestrol acetate (MGA, Zoetis Animal Health, Parsippany,
NJ) for 14 d. On d 33, heifers were injected with prostaglandin F2α in the neck region. For 2016, heifers
were randomly assigned to 1 of 2 treatments: CONTROL: 5 mL i.m. Lutalyse (5 mg/mL dinoprost
tromethamine, Zoetis Animal Health, n = 95) or HiCON: 2 mL s.c. Lutalyse HighCon (12.5 mg/mL
dinoprost tromethamine, Zoetis Animal Health, n = 95). In 2017, heifers (n = 98) were administered 2
mL s.c. Lutalyse HighCon (2017).

Table 1. Estrus response times for yearling heifers given 2 alternate prostaglandin F2α injections in a
MGA-PG estrus synchronization protocol
P-value2

Treatment1
Estrus response, %

CONTROL

HiCON

SEM

TRT

Location

T×L

≤ 60 h

48

72 h

22

59

5.2

0.15

0.07

0.81

16

4.3

0.27

0.69

0.72

≤ 72 h

71

75

4.7

0.51

0.08

0.96

Total Response

82

87

3.9

0.40

0.85

0.40

Heifers administered 1 of 2 alternate PGF2α injections in the neck region on d 33 as part of a MGA-PG protocol. CONTROL:
5 mL i.m. Lutalyse (5 mg/mL dinoprost tromethamine, Zoetis Animal Health, Parsippany, NJ, n = 95) or HiCON: 2 mL s.c.
Lutalyse HighCon (12.5 mg/mL dinoprost tromethamine, Zoetis Animal Health, n =95).
2
TRT: PGF2α injection treatment main effect, Location: Location main effect, T×L: PGF2α injection treatment by location interaction.
1

Table 2. Pregnancy rates of yearling beef heifers given one of two alternate prostaglandin F2α injections
P-value2

Treatment1
CONTROL

HiCON

AI pregnancy , %

63

60

5.3

0.62

0.06

0.03

Total pregnancy4, %

98

93

2.7

0.11

0.96

0.85

3

SEM

TRT

Location

T×L

Heifers administered 1 of 2 alternate PGF2α injections in the neck region on d 33 as part of a MGA-PG protocol. CONTROL:
5 mL i.m. Lutalyse (5 mg/mL dinoprost tromethamine, Zoetis Animal Health, Parsippany, NJ, n = 95) or HiCON: 2 mL s.c.
Lutalyse HighCon (12.5 mg/mL dinoprost tromethamine, Zoetis Animal Health, n = 95).
2
TRT: PGF2α injection treatment main effect, Location: Location main effect, T×L: PGF2α injection treatment by location interaction.
3
Pregnancy diagnosed via transrectal ultrasonography a minimum of 51 d after PGF2α injection.
4
Final pregnancy diagnosis conducted via transrectal ultrasonography a minimum of 107 d after PGF2α injection.
1

The following year, in 2017, additional
yearling Angus-based heifers located at
WCREC (2017, n = 98) were exposed to an
MGA-PG protocol. Heifers were managed
the same as L1, except all heifers received
2 mL s.c. Lutalyse HighCon. Heifers were

observed for estrus activity for 4 d after PG
injection and AI 12 h after detection. Those
not detected (n = 13) were given a second
injection of Lutalyse HighCon and placed
with bulls for a 60 d breeding season.

Initial BW was similar (P = 0.36) between treatments (729 vs. 739 ± 8 lb, CONTROL vs. HiCON), but differed (P = 0.01)
between locations (750 vs. 719 ± 7 lb, L1 vs.
L2). Additionally, BW at first pregnancy
diagnosis was similar (P = 0.26) between
treatments (858 vs. 871 ± 9 lb, CONTROL
vs. HiCON), but also differed (P = 0.04)
by location (851 vs. 875 ± 9 lb, L1 vs. L2).
Heifers at L2 had a greater ADG (P < 0.01)
between prebreeding and AI pregnancy
diagnosis compared with heifers at L1 (2.0
vs. 2.9 ± 0.07 lb/d). At final pregnancy
diagnosis, heifer BW was similar (P = 0.71)
between locations (928 vs. 941 ± 31 lb, L1
vs. L2), and treatments (P = 0.85; 939 vs.
933 ± 24 lb, CONTROL vs. HiCON). The
discrepancy in BW and ADG by location is
caused by L2 heifers starting at a lower BW
at initiation of the trial, but due to a higher
energy ration fed through the treatment
period, compensating to a similar final BW.
Percentage of heifers detected in estrus
is summarized in Table 1, and was similar
between treatments at ≤ 60 h (P = 0.15), ≤
72 h (P = 0.51), and at 72 h (P = 0.27). There
was a tendency (P > 0.07) for a location
effect on estrus response timing at ≤ 60 h
(60 vs. 47 ± 5%, L1 vs. L2) and at ≤ 72 h (78
vs. 67 ± 5%, L1 vs. L2). Different management practices were implemented at each
location, and likely caused the tendency for
location to have an effect on estrus response
times.Total percentage of heifers observed
in estrus throughout the detection period
was similar between treatments (P = 0.40).
Estrus response times for CONTROL,
HiCON and 2017 groups is displayed in
Figure 2.
There was a location × treatment interaction (P = 0.03) for AI pregnancy rates at
AI pregnancy diagnosis between L1 (44 vs.
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64 ± 7.0%, CONTROL vs. HiCON) and L2
(73 vs. 62 ± 7.2%, CONTROL vs. HiCON).
This is similar to past AI pregnancy rates
reported at WCREC (2016 Nebraska Beef
Report, pp 5–7) and those reported at the
Kelly Ranch (2017 Nebraska Beef Report,
pp 11–12). Final pregnancy rates were
similar between treatments (P > 0.11, Table
2). Results from the present study indicate
s.c. administration of Lutalyse HighCon is
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a suitable alternative to an i.m. injection of
Lutalyse.

Implications/Conclusions
Treatment (Lutalyse vs. Lutalyse HighCon) did not affect estrus timing, pregnancy to AI, final pregnancy rates, BW or
ADG. These results indicate producers can
utilize a s.c. injection of Lutalyse HighCon

to avoid injection site blemishes and reduce
carcass discounts without negatively impacting estrus synchronization or pregnancy rates.
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